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Abstract
It remains unclear whether the genetic risk for late-onset Alzheimer disease (AD) is
linked to premorbid individual differences in general cognitive ability and brain struc-
ture. The objective of the present study was to determine whether the genetic risk
of late-onset AD is related to premorbid individual differences in intelligence quo-
tient (IQ) and characteristics of the cerebral white-matter in children. The study sam-
ple included children of the Generation R Study from Rotterdam, The Netherlands.
IQ was measured using a well-validated Dutch nonverbal IQ test (n = 1908) at ages
5 to 9 years. White-matter microstructure was assessed by measuring fractional
anisotropy (FA) of white-matter tracts using diffusion tensor imaging (DTI) (n = 919)
at ages 9 to 12 years. Genetic risk was quantified using three biologically defined
genetic risk scores (GRSs) hypothesized to be related to the pathophysiology of late-
onset AD: immune response, cholesterol/lipid metabolism and endocytosis. Higher
genetic risk for late-onset AD that included genes associated with immune res-
ponsivity had a negative influence on cognition and cerebral white-matter micro-
structure. For each unit increase in the immune response GRS, IQ decreased by
0.259 SD (95% CI [−0.500, −0.017]). For each unit increase in the immune response
GRS, global FA decreased by 0.373 SD (95% CI [−0.721, −0.026]). Neither choles-
terol/lipid metabolism nor endocytosis GRSs were associated with IQ or cerebral
white-matter microstructure. Our findings suggest that elevated genetic risk for late-
onset AD may in part be manifest during childhood neurodevelopment through alter-
ations in immune responsivity.
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1 | INTRODUCTION
AD is a devastating adult-onset disease that causes progressive and
irreversible brain neurodegeneration. It is the most common cause of
dementia, accounting for more than 60% of the cases.1 People suffer-
ing from AD exhibit insidious and progressive memory loss usually
associated with behavioral changes. As the disease progresses, other
spheres of cognition such as language, visuospatial skills or executive
functions become gradually impaired, leading to complete loss of the
“sense of self”.2 These symptoms probably result from brain atrophy,
which at early stages affects the hippocampus and entorhinal cortex.3
Nevertheless, brain white-matter abnormalities are among the
earliest pathophysiological alterations detected in people suffering
from AD.4 It has been observed, for example, that subjects in preclini-
cal or prodromal stages already exhibit widespread abnormalities of
brain white-matter, likely associated with altered microglial activity.5-8
Furthermore, disturbances of axonal transport, oligodendrocyte func-
tion and myelination have been observed in young animal models of
AD.9,10 Altogether these findings suggest that cortical atrophy is pre-
ceded by brain white-matter alterations, which might manifest
decades prior to the onset of clinical symptoms.
Furthermore, brain white-matter alterations might contribute to
the impaired cognitive abilities that occur in individuals with
AD. Various epidemiological studies have shown that in both children
and young adults, low intelligence quotient (IQ) and low linguistic abil-
ity are strong predictors of poor cognitive function and AD diagnosis
later in life.11,12 Likewise, impairments in memory retention and
abstract reasoning have been observed in individuals who are later
diagnosed with AD.13 Although it is unknown how cognitive ability
early in life relates to AD, it has been suggested that “cognitive
reserve” attenuates the impact of neurodegenerative processes. In
this way, individuals with poorer cognitive reserve have a higher risk
of developing AD in comparison to individuals with higher cognitive
reserve.
There are two types of AD that are defined by the age of onset
of the symptoms: early-onset (familial) and late-onset (sporadic).
Although the cause of late-onset AD is unknown, genetic susceptibil-
ity appears to play a crucial role.14 Several genes are known to harbor
risk variants, and among them the ε4 allele of the APOE gene is the
strongest known genetic risk factor for late-onset AD.15,16 Approxi-
mately, one-third of the total phenotypic variance of late-onset AD is
explained by common single nucleotide polymorphisms (SNPs).17 A
total of 19 SNPs have been identified in the largest meta-analysis of
genome-wide association data conducted to date.18 Additionally, a
rare variant with an effect-size similar to that of APOE-ε4,
rs75932628 in the TREM2 gene, has also been observed to increase
the risk for late-onset AD.19
The objective of this study was to determine whether the genetic
risk of late-onset AD is related to premorbid differences in general
cognitive ability and cerebral white-matter integrity during childhood.
We developed biologically informed genetic risk scores (GRSs) and
examined their association with IQ and cerebral white-matter frac-
tional anisotropy (FA) in children from the Generation R Study. GRSs
were constructed based on three pathways that have been shown to
be related to the etiology of late-onset AD: immune response, endo-
cytosis, and cholesterol/lipid metabolism.20
2 | METHODS
The current work was embedded in the Generation R Study, an ongo-
ing population-based prospective cohort study carried out in Rotter-
dam, the Netherlands. The Generation R Study was designed to
identify early environmental and genetic causes as well as underlying
pathways leading to normal and abnormal growth, development and
health.21,22
2.1 | Ethical issues
The Generation R Study, its general design, aims and specific mea-
surements have been approved by the Medical Ethical Committee of
Erasmus MC, Rotterdam. Written informed consent was obtained
from the parents for all data collected as a part of the study. At the
start of each phase, mothers and their partners received written and
oral information about the study. Even with consent of the parents, if
the child was not willing to participate, no measurements were
performed.23
2.2 | Participants
The sample included children of the Generation R Study for whom
IQ, diffusion tensor imaging (DTI) and genetic data were available
(in total 5756 children). Children without Northwestern European
ancestry (n = 2926), without IQ data or an IQ score lower than
70 (n = 797) were excluded from the sample. We restricted the
study-population to Northwestern European children, because
GRSs were based on studies performed in individuals of European
ancestry. Participants with an IQ below 70 were excluded to assure
that the association between outcome and exposure was indepen-
dent from severe intellectual disability.24 Moreover, to assure inde-
pendence of observations, we also excluded randomly selected
siblings (n = 125). As a result, the study sample corresponded to
1908 children.
2.3 | IQ assessment
IQ of children was assessed using the Snijders Oomen Nonverbal
Intelligence Test 2.5-7-Revised (SON-R 2.5-7), which is suitable for
children above the age of 2.5 years and does not require the use of
spoken or written language.24 The full SON-R 2.5-7 test comprises six
subtests that evaluate six different cognitive domains. However, due
to time constraints, children underwent two subtests: categories and
mosaics, which measure abstract reasoning and spatial visualization,
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respectively. The correlation coefficient between the score obtained
from these two subtests and the total set of all six subtests was rela-
tively high in a previous study (r = .86). Raw scores derived from the
two SON-R 2.5-7 subtests were converted into IQ scores that were
specific for each age group of the children.25 Low-performance levels
with respect to abstract reasoning and spatial visualization have been
associated with the subsequent development of AD and therefore
could be considered a good predictive tool.13
2.4 | Brain white-matter microstructure
Individual differences in the microstructure of brain white-matter in
children were assessed with MRI using DTI. DTI takes advantage of
anisotropic diffusion of water molecules in tissues to quantitatively
detect individual differences in the microstructural properties of brain
white-matter.26 Among the measures generated by DTI are scalar
parameters that reflect the total amount of anisotropic diffusion, such
as FA. FA expresses the relationship between axial and radial diffusiv-
ity and thus changes in any of those parameters will have an impact
on FA. Increased axonal density, reduced axonal caliber and/or
increased degree of myelination will all lead to reduced radial diffusiv-
ity and therefore an elevated FA. Accordingly, FA is highly sensitive to
individual differences in white-matter microstructure, but limited in its
specificity.26
DTI data included in the present article were acquired during the
second neuroimaging wave, which included high-resolution structural
MRI, 35-direction diffusion weighted imaging, and a 6 minutes 2 sec-
onds resting-state functional MRI scan.27 Data were acquired using a
3 Tesla GE Discovery MR750w MRI System scanner (General Electric,
Milwaukee, Wisconsin) using an 8-channel head coil for signal recep-
tion.27 Details on how DTI data were generated have been explained
in detail in previous publications.27-29 Briefly, children underwent a
mock scanning session before the actual MRI scan. DTI data were
acquired using a single shot, echo-planar imaging sequence and
processed using the FMRIB Library and the Camino Diffusion MRI
Toolkit.29
2.5 | Genetic data
DNA from children was extracted from the blood of the umbilical cord
at birth. In case blood of the umbilical cord was not available, DNA
was extracted from a blood sample that was obtained by venipuncture
during the first visit of the child to the Generation R Research Cen-
ter.23 Genetic data were generated by a genome-wide association
scan using Illumina HumanHap 610 or 660 Quad chips (Illumina, Inc,
San Diego, California), following manufacturer protocols. Genotype
calling was performed on normalized data of allele signal-intensity
using the Genecall module from Illumina Genome Studio (version
1.1.0.28426). To keep only good-quality samples, the quality metric
provided by Illumina Genome Studio was used; in this way, samples
with scores below 97.5% were excluded.30
The way in which DNA quality control was performed has been
described in detail before.29 In short, individuals with low call rates
(<97.5%) or sex mismatches were excluded. SNPs with low call rates
(<95%) were excluded. Ethnic composition was estimated by identity-
by-state analysis using multidimensional scaling. Participants with
more than four standard deviations (SDs) from a European reference
panel (HapMap CEU) on the first four principal components were con-
sidered as non-northwestern Europeans. In order to maximize genome
coverage, MACH (version 1.0.15) was used to impute genotypes at
each of the autosomal SNPs of the Haplotype Reference Consortium
(HRC) reference panel for Europeans and European-Americans.
Criteria to determine which SNPs to include in the imputation step
included: SNP call rate < 98%, statistically significant departures from
Hardy-Weinberg equilibrium (P < 10−7) and low minor allele fre-
quency <1%.21,23
2.6 | Data analyses
2.6.1 | Diffusion tensor imaging
Confirmatory factor analysis using lavaan package was used to com-
pute global DTI FA.29 Briefly, multiple tracts were summarized as a
single latent factor and the predicted factors scores for each subject
were generated.29 These tracts included: right and left cingulum bun-
dle (CGC), right and left corticospinal tract, forceps major and forceps
minor of the corpus callosum, right and left inferior longitudinal fascic-
ulus (ILF), right and left superior longitudinal fasciculus and right and
left uncinate fasciculus .29
2.6.2 | Genetic risk scores
To construct the GRSs we considered SNPs that were associated with
late-onset AD at a genome-wide significance level (P ≤ 5 × 10−8) and
were replicated in independent data sets. Consequently, 22 SNPs
were considered for inclusion: one SNP for TREM2.1-3 3
(rs75932628), two SNPs that define APOE-ε4 (rs429358 and rs7412),
and 19 SNPs that were identified by the IGAP consortium
(rs10498633 in SLC24A4-RIN3, rs10792832 in PICALM, rs10838725
in CELF1, rs10948363 in CD2AP, rs11218343 in SORL1, rs11771145
in EPHA1, rs1476679 in ZCWPW1, rs17125944 in FERMT2, rs190982
in MEF2C, rs2718058 in NME8, rs28834970 in PTK2B, rs35349669
in INPP5D, rs4147929 in ABCA7, rs6656401 in CR1, rs6733839 in
BIN1, rs7274581 in CASS4, rs9331896 in CLU, rs983392 in MS4A6A,
and rs9271192 in HLA-DRB5-DRB1). From the 22 SNPs originally con-
sidered, 21 remained after we excluded rs9271192 in the HLA-DRB5-
DRB1 gene, because its imputation quality was below the generally
accepted threshold (R2 < .30).
GRSs were constructed based on four pathways that have been
shown to be related to the etiology of late-onset AD: immune response,
endocytosis, cholesterol/lipid metabolism, and protein ubiquitination.20
To assign the SNPs to the pathways we used information on gene
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ontology from previous publications and Gene Network.31-33 Five of the
21 SNPs could not be assigned to any pathway. Only one SNP could be
assigned to protein ubiquitination, and therefore this pathway was not
considered in the analysis. Thus, we ended up with 15 SNPs distributed
in three pathways: immune response, endocytosis and cholesterol/lipid
metabolism (Table 1). For each of the three pathways we calculated a
weighted GRSs by adding the product of SNP dosages and their respec-
tive reported effects (Odds-ratio [OR]; Table 1), according to the formula
below using R (version 3.6.2).34
GRS=
Xn
i
SNPdosagei*log ORð Þi
2.7 | Statistical analysis
To analyze the association between IQ, microstructural properties of
the brain white-matter (global FA) and the GRSs we used multiple linear
regression. We modeled IQ as an outcome and the three GRSs (immune
response, endocytosis and cholesterol/lipid metabolism) as predictors in
a single regression model. The same approach was used to analyze the
association between global FA and the three GRSs. Both models were
adjusted for age, gender and four principal components of ancestry. To
help interpreting regression coefficients, we computed z-values for IQ
and global FA. A complementary analysis was performed including chil-
dren with an IQ lower than 70 using not only the original analysis, but
also k-means cluster analysis. Variables used in the clustering included
IQ, global FA and immune response GRS. Two clusters were computed.
T-tests were used to compare the clusters. All analyses were performed
using R (version 3.6.2) and R-packages.34
3 | RESULTS
To study the association of genetic risk for late-onset AD on IQ and
global FA, we implemented three biologically informed GRSs: immune
response, endocytosis and cholesterol/lipid metabolism (see
section 2).
3.1 | General characteristics of the sample
The sample included 1908 children, 51% (n = 973) of whom were
female. IQ was assessed in children at a mean age of 6.09 years
(SD = 0.40). The mean IQ score of children of the sample was
105.60 (SD = 13.58), ranging from 71 to 150. From the sample,
919 children had DTI data available. Children were subjected to DTI
at a mean age of 10.18 years (SD = 0.62). The mean global FA of
children was 0.23 (SD = 13.58), ranging from −6.98 to 5.47. The
immune response GRS ranged from −0.646 to 1.027 with a mean of
−0.073. The endocytosis GRS ranged from −1.340 to 3.003 with a
mean of 0.276. The cholesterol/lipid metabolism GRS ranged from
−0.261 to 0.867 with a mean of 0.366. As previously showed IQ
exhibited a significant positive association with global FA. For each
unit increase in global FA, IQ increased by 0.111 SD (95% CI [0.045,
0.177]; P = .001).29
TABLE 1 SNPs that were used to build the GRSs.
SNP Gene Odds-ratio Immune response Endocytosis Cholesterol/lipid metabolism
rs4147929 ABCA7 1.151 *
rs7412 APOE2 0.671 *
rs429358 APOE4 3.861 *
rs6733839 BIN1 1.221 *
rs10948363 CD2AP 1.101 *
rs9331896 CLU 0.861 * *
rs6656401 CR1 1.181 *
rs11771145 EPHA1 0.901 *
rs35349669 INPP5D 1.081 *
rs190982 MEF2C 0.931 *
rs983392 MS4A64 0.901 *
rs10792832 PICALM 0.871 *
rs28834970 PTK2B 1.101
rs11218343 SORL1 0.771 * *
rs75932628 TREM2 2.432 *
Note: 15 SNPs could be assigned to at least one of the pathways identified as showing enrichment for association with late-onset AD. The pathway
protein ubiquitination was excluded because none of the SNPS could assigned to this pathway. Notice that only immune/inflammatory response and
endocytosis are completely independent pathways.
Abbreviations: Immune resp., immune response; Cholesterol/lipid met., cholesterol/lipid metabolism; Synaptic trans., synaptic transmission; 1, OR
extracted from reference 18; 2, OR extracted from reference 19; *, belongs to.
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3.2 | Effect of GRS on IQ
We observed that in comparison to the other scores, the immune
response GRS exhibited a significant negative association with IQ. For
each unit increase in the immune response GRS, IQ decreased by
0.259 SD (95% CI [−0.500, −0.017]). In contrast, no significant associ-
ations were observed between either the endocytosis or cholesterol/
lipid metabolism GRSs with IQ (Table 2). Moreover, we also found no
evidence for an interaction between immune response GRS and gen-
der, or between immune response GRS and age in relation to IQ (all P-
values >.2) (Table S1; and Figures S1 and S2).
3.3 | Effect of GRS on global FA
The immune response GRS also exhibited a significant negative associa-
tion with global FA. For each unit increase in the immune response GRS,
global FA decreased by 0.373 SD (95% CI [−0.721, −0.026]). Similar to
the results for IQ, the GRSs for neither endocytosis nor cholesterol/lipid
metabolism were significantly associated with global FA (Table 2). We
did neither find evidence for an interaction between immune response
GRS and gender, nor between immune response GRS and age for global
FA (all P-values >.1) (Table S1 and Figures S3 and S4).
3.4 | Impact of IQ filter
We wanted to know whether children with moderate to severe intel-
lectual disability (IQ < 70) tended to also have lower global FA and
higher immune response GRS. When we included them in the original
analysis described above, we observed that the P-values slightly
increase, while coefficients were only mildly different (Table S2). Next,
to further explore the associations, we subjected the same data set to
k-means cluster analysis. Two clusters emerged, in which children
from cluster 1 had higher IQ, higher global FA, and a lower immune
response GRS compared with those of cluster 2 (all P < .001) (Table 3).
Furthermore, the effect of the immune response GRS did not depend
on the number of SNPs it contains. The regression model
implemented to test this hypothesis showed that the effect of an
overall GRS is not statically significant associated with neither IQ nor
global FA (Table S3).
4 | DISCUSSION
The objective of the present study was to determine whether
the genetic risk of late-onset AD is associated with premorbid
individual differences in general cognitive ability and cerebral
white-matter microstructure. Genetic risk was evaluated through
biologically informed GRSs that were constructed based on
widely held hypothesis about the pathophysiology of late-onset
AD. We found that the genetic risk for late-onset AD associated
with immune responsivity negatively influenced IQ and cerebral
white-matter microstructure. Accordingly, children with a high
immune response GRS were more likely to have lower IQ and
global FA, the latter of which is thought to reflect decreased
axonal density, increased axonal caliber, and/or decreased axonal
myelination.
TABLE 2 Summary of k-means
cluster analysis.
GRS β SE CI lower CI upper P-value
IQ
Immune response −.259 .123 −.500 −.017 .036
Endocytosis −.015 .116 −.243 .212 .895
Cholesterol/lipid metabolism .030 .031 −.031 .092 .335
FA
Immune response −.373 .177 −.721 −.026 .035
Endocytosis .122 .167 −.205 .449 .465
Cholesterol/lipid metabolism −.077 .046 −.167 .013 .094
Abbreviations: CI, confidence interval; FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence
quotient; SD, standard deviation; SE, standard error.
Note: Both models were adjusted by age, gender and four principal components of ancestry. Coefficients
were calculated using z-values therefore β represents change in terms of SD from the mean.
TABLE 3 Summary of k-means
cluster analysis.
Cluster 1 Cluster 2
StatisticsMean SD Mean SD
IQ 111.850 13.132 101.748 14.161 t = 11.39, df = 2, P < .001
Global FA 1.140 1.390 −.991 1.473 t = 22.91, df = 2, P < .001
Immune response GRS −.154 .157 .032 .166 t = −17.74, df = 2, P < .001
Abbreviations: FA, fractional anisotropy; GRS, genetic risk score; IQ, intelligence quotient; SD, standard
deviation.
Note: Analysis included children with moderate to severe intellectual disability (IQ lower than 70). Values
for IQ, global FA and immune response GRS are showed for the two clusters that were computed.
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A few studies have examined the association between the genetic
risk of late-onset AD using GRSs and premorbid phenotypic traits,35-37
including one using overlapping data from the Generation R Study.37
The results of these studies are partly contradictory. For example, we
and others found no evidence of an association between the genome-
wide GRS for AD risk and various outcomes related to education, cogni-
tion and behavior in children.35,37 However, this was only true for GRSs
constructed from SNPs that were associated with late-onset AD at a
genome-wide significance level (P ≤ 5 × 10−8).35 Furthermore, other
studies using a similar approach, found that the genetic risk for AD was
significantly associated with poorer cognition and decreased hippocam-
pal volume in children 6 to 14 years of age and healthy young
adults.36,38 Notably, in both studies GRSs were constructed using the P-
values of the examined SNPs with respect to AD diagnosis as cut-off
points. Furthermore, these studies, including our earlier work, did not
construct GRSs on the basis of a priori defined biological pathways.
In contrast to previous studies, we found no evidence for early-
life associations between either IQ or cerebral white-matter micro-
structure related to genes involved in cholesterol/lipid metabolism,
such as APOE. For instance, our findings contrast those of Chang et al,
who reported that AD genetic risk, specifically with respect to that of
APOE-ε4, is negatively associated with brain and cognitive develop-
ment in children. They found that on average in comparison to non-
carriers, children carrying APOE-ε4 have a smaller hippocampus,
reduced hippocampal FA, and thinner entorhinal cortex, which was
associated with poorer performance on attention and working mem-
ory tasks.39 These findings also contrast those of Acqua et al and a
recent meta-analysis, both of which found no evidence of association
between APOE genotype and cognitive traits or brain structure in
younger persons.40,41
4.1 | Immune response, IQ and cerebral white-
matter microstructure
Our findings suggest that genetic risk for late-onset AD might in part be
associated with immune responsivity, which was associated with both
general cognitive ability and cerebral white-matter microstructure. Nota-
bly, we did not correct for multiple comparisons as we employed a sin-
gle model comprising all comparisons for each outcome. Our data are
corroborated by the finding that the AD risk score capturing the
immune response has also been shown to associate modestly with
white matter lesions in adults, confirming the link in a separate, yet dif-
ferent population.33 These findings raise the question as to how genes
involved in the immune response may contribute to differences in IQ?
Given the association between the immune response GRS and changes
in cerebral white-matter microstructure, our data suggest that genes
involved in immune responses might exert their influence on IQ indi-
rectly. Possibly, genes involved in the immune response could drive
changes in myelination and/or axonal growth that ultimately have an
impact on IQ. Alternatively, the genes involved in the immune response
might also impact cognition by participating in plasticity of synapses dur-
ing development and adulthood.42
How could genes involved in immune response alter the micro-
structure of the cerebral white-matter, that is, myelination and/or axonal
morphology? Human and animal studies have shown that EPHA1,
MEF2C, INPP5, CR1, CLU, MS4A6A and TREM2 are expressed in
microglia, which are the main cell type of the innate immunity in the
central nervous system (CNS).43-45 Microglial cells, which represent
nearly 20% of glial cells in the cerebrum, might contribute to myelination
and axonal growth in an immune “surveillant” and an immune “active”
manner.46 Surveillant microglia support the survival of oligodendrocytes
as well as the differentiation of oligodendrocyte progenitor cells
(OPCs).47 In contrast, active microglia stimulate remyelination not only
by removing debris created by the breakdown of myelin but also by
priming the efficient recruitment of OPCs.48,49 Likewise, active micro-
glial cells facilitate neuronal survival and axonal growth by supplying
neurons with neurotrophic factors, including brain-derived neurotrophic
factor and nerve growth factor among others.50
4.2 | Implications of our findings
Our findings suggest that intelligence, cerebral white-matter and
Alzheimer disease (AD) share a common set of genes linked to the
immune response. This conclusion has important implications. First,
they support the hypothesis that pathophysiological changes underly-
ing the characteristic neurodegeneration and neurological symptoms
in people with AD begin early in life. Accumulation of β-amyloid and
formation of neurofibrillary tangles may indeed constitute only part of
the neurodegenerative process.51 Furthermore, our results also sug-
gest that dysfunctional white-matter may be an insufficiently
unappreciated component of the pathogenesis of AD.4 In this respect,
it is important to note that white-matter abnormalities have been
detected in preclinical stages of AD preceding overt neurodegenera-
tive changes in the cerebral cortex.7 Indeed, white-matter demyelin-
ation as well as signs of neuronal dysfunction can occur prior to the
accumulation of β-amyloid and the formation of neurofibrillary
tangles.4,51
Second, our findings highlight the importance of the immune sys-
tem in cerebral white matter development. Accordingly, diverse risk
factors, whether they might be genetic or environmental, that inter-
fere with the “normal” functioning of the immune system potentially
contribute to AD risk. This hypothesis is consistent with several GWA
studies of AD risk, which have implicated a group of linked to immune
responsivity, particularly those related to innate immunity.18,20,52 It is
possible that these genetic factors confer risk for AD by directly
compromising the function of microglial cells, and perhaps indirectly
for astrocytes, oligodendrocytes, and ultimately neurons, which may
well establish the basis for our observed premorbid association with
cerebral white-matter microstructure.
Third, our findings open the possibility of developing sensitive
and specific criteria that might facilitate AD diagnosis and therapeutic
intervention. These criteria would be envisioned as based on a combi-
nation of polygenic risk profiles, cognitive evaluation, and cerebral
DTI. Together, this integrated approach might help to identify
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individuals at high risk for developing AD during the early stages of
the disease, thereby allowing for preventative interventions, such as
cognitive training and lifestyle changes.53
4.3 | Strengths and limitations
Although the effects of the genetic risk for AD have been studied exten-
sively in older populations, their impact on children has been less fre-
quently investigated. To our knowledge, this is the first study to utilize
biologically informed GRSs in childhood to examine associations with cog-
nition or white-matter microstructure. In contrast to earlier work within
the Generation R Study and other cohorts, our study used GRSs that
were constructed by clustering variants according to pathways previously
associated with AD. Although this approach constitutes a strength, it is
also a limitation given that the findings are based on a limited number of
SNPs without being certain of the genes being influenced. Future studies
are warranted to further explore the potential causality and biological
mechanisms underlying these genetic associations.
It is important to note that our findings suggesting that the generic
risk for developing AD is associated with both intelligence and global FA
should be interpreted with caution. Given that FA only denotes individ-
ual differences in the microstructural properties of cerebral white-mat-
ter, lower FA does not necessarily imply a particular pathological
change. Moreover, the size of the effects we found was relatively small
(about 1% of the phenotypic variance of IQ or FA). Therefore, this find-
ing likely reflects the complex multidimensional nature of the brain and
cognitive development. Studies attempting to replicate these findings
will be important to validate these results.
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